Category: medical

Would You Cut Someone’s Throat for Money

No Comments

The hed is instructive, “Chicago Hospital Accused of Cutting Throats for $160,000.”

When people talk about how the private sector solves everything, just remember this story:

A surgeon at Chicago’s Sacred Heart Hospital cut a hole in Earl Nattee’s throat on Jan. 3, the day before he died. It’s not clear why.

The medical file contained no explanation of the need for the procedure, called a tracheotomy, according to a state and federal inspection report that quotes Sacred Heart’s chief nursing officer as saying it happened “out of the blue.” Tracheotomies are typically used to open an air passage directly to the windpipe for patients who can’t breathe otherwise.

Now, amid a federal investigation into allegations of unneeded tracheotomies at the hospital, Nattee’s daughter, Antoinette Hayes, wonders whether her father was a pawn in what an FBI agent called a scheme to defraud Medicare and Medicaid.

“My daddy said, ‘They’re killing me,’” Hayes recalled, in reference to the care he received at the hospital.

Based in part on surreptitious tape recordings, an FBI affidavit lays out allegations that a Sacred Heart pulmonologist kept patients too sedated to breathe on their own, then ordered unneeded tracheotomies for them — enabling the for-profit hospital to reap revenue of as much as $160,000 per case.

They have witnesses who wore wires, and a number of doctors, as well as the CEO of the for profit (notwithstanding the Catholic hospital sounding name) hospital.

There is a reason why governments need to aggressively regulate, or operate, critical services, because incentives to produce good behavior are either ineffective, or more expensive than explicit regulation.

H/t JR at the Stellar Parthenon BBS.

Why Species Patents Suck, Part Gazillion

No Comments

Stuck in the middle of an article about the Middle East Respiratory Syndrome coronavirus (MERS) is this tidbit about how a lab is claiming all rights to its genome, impeding research on the illness:

But impeding an effective response is a dispute over rights to develop a treatment for the virus. The case brings to the fore a growing debate over International Health Regulations, interpretations of patent rights, and the free exchange of scientific samples and information. Meanwhile, the epidemic has already caused forty-nine cases in seven countries, killing twenty-seven of them.

At the center of the dispute is a Dutch laboratory that claims all rights to the genetic sequence of the Middle East Respiratory Syndrome coronavirus [MERS-CoV]. Saudi Arabia’s deputy health minister, Ziad Memish, told the WHO meeting that “someone”–a reference to Egyptian virologist Ali Zaki–mailed a sample of the new SARS-like virus out of his country without government consent in June 2012, giving it to Dutch virologist Ron Fouchier of Erasmus Medical Center in Rotterdam.

“The virus was sent out of the country and it was patented, contracts were signed with vaccine companies and anti-viral drug companies, and that’s why they have a MTA [Material Transfer Agreement] to be signed by anybody who can utilize that virus, and that should not happen,” Memish said.

Though Memish referred to a “patent,” the Dutch team has not patented the viral genetic sequence but has placed it under an MTA, which requires sample recipients to contractually agree not to develop products or share the sample without the permission of Erasmus and the Fouchier laboratory. Memish said that the Dutch MTA was preventing Saudi Arabia from stopping the MERS-CoV outbreak, which appears to have started eleven months ago in the Eastern part of his country. The Dutch team denies the MTA is slowing work on the outbreak, saying it has given virus samples to any lab that has requested it.

If you thought that the idea of patenting software was bad, patenting genes and species is a whole new level of f%$#ed up.

In today’s world, when we are in the middle of a potential epidemic, our first priority is to make the world safe for scumbag profiteers.

How Worship of the Unbridled Market is Taking the United States to 3rd World Nation Status

No Comments

Premature babies are dieing of starvation because feeding babies is not profitable enough for sufficient stocks to be maintained:

Because of nationwide shortages, Washington hospitals are rationing, hoarding, and bartering critical nutrients premature babies and other patients need to survive. Doctors are reporting conditions normally seen only in developing countries, and there have been deaths. How could this be allowed to happen?

………

 Except for a mind-boggling problem that Atticus’s [A child born 4 months early, and currently in the NICU] hospital—one of the most prominent in the country—has been powerless to solve: Atticus isn’t receiving some of the critical nutrients he needs to survive.

 Doctors and pharmacists say that because of nationwide shortages caused by a combination of factors—manufacturing problems, a market with few incentives for companies to produce low-profit drugs, and the government’s delayed and inadequate action—thousands of patients are being malnourished.

 ………

 Experts call the nutrient shortage a public-health crisis and a national emergency—and are astounded that the government and manufacturers have let the situation become so dire.

 “Children are dying,” says Steve Plogsted, a clinical pharmacist who chairs the drug-shortage task force of the American Society for Parenteral and Enteral Nutrition (ASPEN). “They’re not getting any calcium or any zinc. Or they’re not getting any phosphorous, and that can lead to heart standstill. I know of a neonate who had seven days without phosphorous, and her little heart stopped.”

 “I’ve never seen anything like this in my entire career, and I’ve been a pharmacist for 40-some years,” says Michael Cohen, president of the nonprofit Institute for Safe Medication Practices (ISMP) and a 2005 MacArthur Foundation fellow. “This should never be allowed to happen.”

 There are 300 drug, vitamin, and trace-element shortages in the US, the highest number ever recorded by the University of Utah Drug Information Service, which began tracking national shortages in 2001. Approximately 80 percent of these are generic injectables, or drugs given intravenously.

 ………

 The nutrients in shortage aren’t rare. “We’re talking about zinc, phosphorous, calcium—trace elements,” says CHA president Mark Wietecha. “These aren’t the latest genetically modified drugs or something coming out of modern high-tech environments. These have been around for decades.”

………

 Some hospitals have resorted to bartering with one another to secure even a small supply of nutrients, and many are rationing.

 At least one NICU in the District is administering some trace elements only three days a week instead of seven. At Atticus’s hospital, no patients heavier than 2½ kilograms (5½ pounds), including NICU babies, are getting intravenous phosphorous. “You could have a brand-new, full-term baby and they don’t qualify,” a staff member says. “There are really sick babies and one-, two-, three-year-olds that don’t get anything at all because we’re rationing it for our tiniest preemies.”

 ………

 When Miguel Sáenz de Pipaón, a neonatologist at a prominent hospital in Madrid, arrived in the US for a research visit, he was stunned by the nutrition shortages.

 “It’s crazy,” he says. “That doesn’t happen in Europe.” He noted that the US relies on a 25-year-old lipid emulsion, which is in shortage, while European hospitals use a newer version that’s readily available. Rather than import the newer emulsion, the US has left many patients without any lipids at all.

 The only shortage Sáenz de Pipaón could recall in Spain occurred two years ago when a Canadian factory stopped making trace elements. His hospital pharmacy immediately secured the product from a Swedish manufacturer and had it for patients within two days.

 Hospital staff wonder why the FDA hasn’t already put a process in place to streamline foreign inspections and certifications so that labs abroad can manufacture emergency supplies on short notice.

 Jensen says the FDA is working on it and that imported nutrients will be shipped soon: “It took a long time to find companies willing to do it, mainly because they couldn’t meet US needs and didn’t have the ability to ramp up for the US. The good news is we’ve got different firms willing to do this for phosphates, zinc, and trace elements. We moved as quickly as we could.”

Yes, moved as quickly as they could. (Not)

You can be certain that a (castrated over the past few decades) FDA is consulting with the manufacturers, so as to avoid hurting their business models.

“The FDA has repeatedly told us that the shortages are short-term and that they don’t need to import yet,” says neonatologist Steve Abrams of Texas Children’s Hospital. “There’s been a general sense that this problem will go away if we just wait until next Tuesday, and next Tuesday just hasn’t come for the last 2½ years.

They keep kicking the can down the road, because they, and the congressmen who vote on their budget, ahve been captured by pharma.

All right, Mr. DeMille, I’m ready for my close-up………

No Comments

When this hits the internet, I’ve posted ahead of time, I will be in my doctor’s office, getting a routine colonoscopy.

If you think that this is over-sharing, you will be glad to know that I will not be sharing photographs.

It should be routing, but I am looking to having some real food after the procedure.

I’ve been off of solid food for 36 hours, and NPO since early this morning.

I Hope So

No Comments

Ars Technica asks, “Will the Supreme Court end human gene patents after three decades?“

I think that it likely that they role back patent protections.

These days, they only seem to take patent cases when the United States Court of Customs and Patent Appeals goes too far with patents.  (Which it does with mind-numbing regularity):

Since the 1980s, patent lawyers have been claiming pieces of humanity’s genetic code. The United States Patent and Trademark Office has granted thousands of gene patents. The Federal Circuit, the court that hears all patent appeals, has consistently ruled such patents are legal.

But the judicial winds have been shifting. The Supreme Court has never ruled on the legality of gene patents. And recently, the Supreme Court has grown increasingly skeptical of the Federal Circuit’s patent-friendly jurisprudence.

Meanwhile, a growing number of researchers, health care providers, and public interest groups have raised concerns about the harms of gene patents. The American Civil Liberties Union estimates that more than 40 percent of genes are now patented. Those patents have created “patent thickets” that make it difficult for scientists to do genetic research and commercialize their results. Monopolies on genetic testing have raised prices and reduced patient options.

On Monday, the high court will hear arguments about whether to invalidate a Utah company’s patents on two genes associated with breast cancer. But the legal challenge, spearheaded by the American Civil Liberties Union and the Public Patent Foundation, could have much broader implications. A decision could invalidate thousands of patents and free medical researchers and clinicians to practice medicine without interference from the patent system.

It’s very clear that a gene is a discovery, not an invention, but the patent court believes that you can patent a rainy day (I mean this literally: They approved a patent on weather derivatives in Bilski v. Kappos, which was later overturned by the Supreme Court. This court also allowed for patenting of tax deductions)

India Rejects Evergreening Pharmaceuticals

No Comments

The Indian Supreme Court has rejected a patent for a slightly modified drug, on the basis that it was not a significant change.

The drug companies do this all the time, in order to extend their patents on drugs nearly indefinitely:

People in developing countries worldwide will continue to have access to low-cost copycat versions of drugs for diseases like H.I.V. and cancer, at least for a while.

Production of the generic drugs in India, the world’s biggest provider of cheap medicines, was ensured on Monday in a ruling by the Indian Supreme Court.

The debate over global drug pricing is one of the most contentious issues between developed countries and the developing world. While poorer nations maintain they have a moral obligation to make cheaper, generic drugs available to their populations — by limiting patents in some cases — the brand name pharmaceutical companies contend the profits they reap are essential to their ability to develop and manufacture innovative medicines.

Specifically, the decision allows Indian makers of generic drugs to continue making copycat versions of the drug Gleevec, which is made by Novartis. It is spelled Glivec in Europe and elsewhere. The drug provides such effective treatment for some forms of leukemia that the Food and Drug Administration approved the medicine in the United States in 2001 in record time. The ruling will also help India maintain its role as the world’s most important provider of inexpensive medicines, which is critical in the global fight against deadly diseases. Gleevec, for example, can cost as much as $70,000 a year, while Indian generic versions cost about $2,500 a year.

The ruling comes at a challenging time for the pharmaceutical industry, which is increasingly looking to emerging markets to compensate for lackluster drug sales in the United States and Europe. At the same time, it is facing other challenges to its patent protections in countries like Argentina, the Philippines, Thailand and Brazil.

“I think other countries will now be looking at India and saying, ‘Well, hold on a minute — India stuck to its guns,’ ” said Tahir Amin, a director of the Initiative for Medicines, Access and Knowledge, a group based in New York that works on patent cases to foster access to drugs.

………

In Monday’s decision, India’s Supreme Court ruled that the patent that Novartis sought for Gleevec did not represent a true invention. The ruling is something of an anomaly. Passed under international pressure, India’s 2005 patent law for the first time allowed for patents on medicines, but only for drugs discovered after 1995. In 1993, Novartis patented a version of Gleevec that it later abandoned in development, but the Indian judges ruled that the early and later versions were not different enough for the later one to merit a separate patent.

Leena Menghaney, a patient advocate at Doctors Without Borders, said that the ruling was a reprieve from more expensive medicines, but only for a while.

“The great thing about this ruling is that we don’t have to worry about the drugs we’re currently using,” Ms. Menghaney said. “But the million-dollar question is what is going to happen for new drugs that have not yet come out.”

Others decried the ruling, saying it was further evidence that India does not respect the intellectual property rights of pharmaceutical companies. Last year, India granted what is known as a compulsory license to a generic drug manufacturer to begin making copies of Bayer’s cancer drug Nexavar, and revoked Pfizer’s patent for another cancer drug, Sutent. Both companies have appealed the decisions.

First, evergreening does not serve to create new products, it encourages minor, non-functional, changes to existing products to maintain a monopoly.

Second, compulsory licensing is specifically allowed for under all major international IP and trade regimes.

Unfortunately, when you look at intellectual protections (IP) as property it means that the holder of that monopoly has a God given right to extract unreasonable rents forever.

There is no place where our patent system is more broken than in the evergreening of pharmceuticals, and that is saying a lot.

Another Study Proves that Jenny McCarthy is a Dangerous Loon

No Comments

We have another study showing that there is no connection between vaccines and autism:

There is no link between receiving a number of vaccines early in life and autism, researchers said on Friday.

In a study slated to appear in The Journal of Pediatrics, researchers said there is no association between receiving “too many vaccines too soon” and autism, despite some fears among parents around the number of vaccines given both on a single day and over the first 2 years of life.

As many as one in 50 U.S. school-age children have been diagnosed with autism, up 72 percent since 2007.

………

Researchers from the Centers for Disease Control and Prevention and Abt Associates analyzed data from children with and without autism spectrum disorder (ASD), according to a statement from the journal.

Researchers examined each child’s cumulative exposure to antigens, the substances in vaccines that cause the body’s immune system to produce antibodies to fight disease, and the maximum number of antigens each child received in a single day of vaccination, the journal’s statement said.

The antigen totals were the same for children with and without ASD, researchers found.

Not surprising.

In the normal course of growing up, a child is exposed to hundreds, possibly thousands, of new antigens a day, the idea that adding a dozen or so to that would be received through a series of vaccinations would “cause” autism is ludicrous.

Of course, the antediluvian thinking of the anti-vax crowd has real consequences: we have seen increases in outbreaks of previously nearly vanished childhood diseases resulting from a loss of herd immunity.

Good

No Comments

Jenny McCarthy has been has been dropped from a cancer fundraiser because of her anti-vaccine bullsh%$:

The Ottawa Cancer Foundation has reversed its decision to hire actress and model Jenny McCarthy to headline its one-day fitness fundraiser Bust A Move.

In a statement released late Friday afternoon, the foundation said McCarthy would be replaced by Canadian celebrity fitness instructor and former CFL player Tommy Europe.

The statement said that since the announcement of McCarthy’s appearance, “…attention has shifted away from breast cancer awareness and fundraising.”

On Tuesday, McCarthy was revealed as Bust A Move’s guest fitness instructor, which caused many to question why an organization supporting cancer research would invite someone with a history of promoting erroneous ideas about health and disease.

Despite reams of scientific research to the contrary, McCarthy writes and speaks publicly about the supposed link between child vaccination and autism. The former Playboy Playmate also blames her son’s autism on vaccinations.

Word of McCarthy’s appearance at a charity cancer event sparked a #dropjenny hashtag on Twitter, which generated many comments about whether the actress was a credible choice. Similar online debate occurred on Bust A Move’s Facebook page.

I’m not saying that Jenny McCarthy should not be able to work because of her beliefs, but allowing her to be a spokesperson for anything remotely medical is like having António Egas Moniz (the inventor of the prefrontal lobotomy) as a spokesman for psychological counseling.

Words Cannot Express My Disgust

No Comments

Israel has been administering the Depo-Provera contraceptive to Ethiopian Women without their knowledge:

It isn’t an apology or an acceptance of responsibility. But for the first time, an Israeli government official has admitted what thousands of Ethiopian Jewish women have allegedly known for years – doctors in Israel have been injecting Ethiopian women with long-acting birth control medication known as Depo-Provera without the informed consent of the women. The effect of the shots lasts for months and the practice effectively sterilizes women for that period of time. Many Ethiopian women have reportedly received these shots for years with little or no say in the decision to receive them.

This is bigoted, and this is contemptible.

Whoever was behind this needs to be drummed out of the medical profession.

At least they have put an end to the practice:

Health Ministry Director General Prof. Ron Gamzu has instructed the four health maintenance organizations to stop the practice as a matter of course.

 The ministry and other state agencies had previously denied knowledge or responsibility for the practice, which was first reported five years ago.

 Gamzu’s letter instructs all gynecologists in the HMOs “not to renew prescriptions for Depo-Provera for women of Ethiopian origin if for any reason there is concern that they might not understand the ramifications of the treatment.

This is quite literally the least they could once this came to light.

In addition to being racist, it’s bad medicine. Depo-Provera has a lot of nasty side effects.

Why We Need to Kill Big Pharma, Part LVXXI

No Comments

So, a company buys the rights to a drug for 100 Grand, and takes the price of a vial from $50 to $28,000:

THE doctor was dumbfounded: a drug that used to cost $50 was now selling for $28,000 for a 5-milliliter vial.

The physician, Dr. Ladislas Lazaro IV, remembered occasionally prescribing this anti-inflammatory, named H.P. Acthar Gel, for gout back in the early 1990s. Then the drug seemed to fade from view. Dr. Lazaro had all but forgotten about it, until a sales representative from a company called Questcor Pharmaceuticals appeared at his office and suggested that he try it for various rheumatologic conditions.

“I’ve never seen anything like this,” Dr. Lazaro, a rheumatologist in Lafayette, La., says of the price increase.

How the price of this drug rose so far, so fast is a story for these troubled times in American health care — a tale of aggressive marketing, questionable medicine and, not least, out-of-control costs. At the center of it is Questcor, which turned the once-obscure Acthar into a hugely profitable wonder drug and itself into one of Wall Street’s highest fliers.

At least until recently, that is. Now some doctors, insurance companies and investors are beginning to have doubts about whether the drug is really any better than much cheaper alternatives. Short-sellers have written scathing criticisms of the company, questioning its marketing tactics and predicting that its shareholders are highly vulnerable.

………

But Questcor did almost no research or development to bring Acthar to market, merely buying the rights to the drug from its previous owner for $100,000 in 2001. And while the manufacturing of Acthar is complex, it accounts for only about 1 cent of every dollar that Questcor charges for the drug.

Moreover, the tiny “orphan” market soon became much bigger. Before long, Questcor began marketing the drug for multiple sclerosis, nephrotic syndrome and rheumatologic conditions, even though there is little evidence that Acthar is more effective for those other conditions than alternatives that are far cheaper. And the company did so without being required to prove that the drug actually works. That is because Acthar was approved for use in 1952, before the Food and Drug Administration required clinical trials to show a drug is effective for a particular disease. Acthar is essentially grandfathered in.

How the F%$# does a drug that was approved for use in 1952 remain under IP protection?

I’m increasingly convinced that our current IP regime is an iron triangle between rent-seekers who produce nothing of value, politicians who take their campaign donations, and the the rest of us, who provide the ill-gotten gains that the rent-seekers use to protect their business models.

Why We Need to Destroy Big Pharma

1 Comment

Well, the first answer is a utilitarian answer, we do not need them.

If the government spends 5 out of every 6 dollars spent on medical research, then there is no reason to pay the excessive monopoly rents that they extract from out economy.

But there is also a moral argument, and it is that the large pharmaceutical firms are ineluctably evil.

We have yet another example of this when we discover that they colluded with the government of East Germany to turn their citizenry into unwilling Guinea Pigs:

Major Western pharmaceutical companies carried out tests of medications in the 1980s on patients in communist East Germany, in some cases without the subjects’ knowledge, a media report said Friday.

 “We have documents showing there were contracts between Western drug companies and East German institutions for medical tests,” a staff member at the German national archive told AFP, partially confirming a report in the daily Der Tagesspiegel.

 The newspaper, which examined the documents, reported that more than 50 Western firms had contracts with East Germany’s Health Ministry to carry out a total of 165 medical tests between 1983 and 1989.

 In exchange, the communist authorities were paid up to 860,000 deutschmarks (around 430,000 euros today or $567,000), according to the report, at a time when East Germany was desperate for hard currency.

 Der Tagesspiegel said the companies involved included Bayer, Schering, Hoechst (now Sanofi), Boehringer Ingelheim and Goedecke (today owned by Pfizer).

 It said the test subjects often were not informed, citing seven specific cases in which patients said later they had been unaware they were involved in testing. The national archive said it could not confirm this.

The taxpayers front ⅚ of the money to do the research, but out of some sort of need to “set the free market loose, we give away the property rights so that they can extract monopoly rents.

Enough.

This is an industry that exists only through the grant of exclusive rights by the government.  This is not free enterprise.

We need to make sure that if the taxpayers pay for the research, then the taxpayers own the research.

Jack Klugman Did the Wrong Thing for the Right Reasons

No Comments

When actor Jack Klugman died recently, much was said about his career, but special note was given to his role in the passage of the Orphan Drug Act of 1983.

There can be no doubt here that his motives were good.  He wanted to see that diseases for which there was a limited number of sufferers, and hence limited profit, had drugs developed and produced.

Unfortunately, what seemed like a wonderful idea, subsidies and exclusivity granted to pharma, which had the added allure of providing a free market aura, has made things worse.

About ⅚ of the money spent on medical research is government money.  When one considers the subsidies present under the Orphan Drug Act, that number undoubtedly tops ⁹⁄₁₀ of the funds being from the taxpayers.

BTW, some of the Orphan drugs in question are such “blockbusters” as, “Abilify, Provigil, Vioxx, Botox, and Cialis.”

You see a similar effect with the Drug Price Competition and Patent Term Restoration Act and Colcicine, where a drug that had been in use for 3500 years (no that number is not a typo, the first documented use of the drug is from ≈1500 BCE) went from 9¢ to $4.85 a pill, a 5200+% increase.

The underlying flaw here is the idea that private business is an unalloyed good, so if there is something it will not do, the solution is to subsidize private businesses to do it, even when all indications are that having the government provide this function would provide the most benefit.

This is wrong, and we have seen nearly 40 years of this philosophy, it really became mainstream during the Carter years, has harmed society as a whole.

XTC vs. PTSD, Why Not THC? EIEIO!

3 Comments

There are indications that MDMA (aka Ecstasy, E, X, and XTC) is showing promise in the treatment of post traumatic stress disorder, and limited clinical trials have been ordered:

Hundreds of Iraq and Afghanistan veterans with post-traumatic stress have recently contacted a husband-and-wife team who work in suburban South Carolina to seek help. Many are desperate, pleading for treatment and willing to travel to get it.

 The soldiers have no interest in traditional talking cures or prescription drugs that have given them little relief. They are lining up to try an alternative: MDMA, better known as Ecstasy, a party drug that surfaced in the 1980s and ’90s that can induce pulses of euphoria and a radiating affection. Government regulators criminalized the drug in 1985, placing it on a list of prohibited substances that includes heroin and LSD. But in recent years, regulators have licensed a small number of labs to produce MDMA for research purposes.

(emphasis mine)

I’m an engineer, not a doctor, dammit,* so I really don’t have an informed opinion as to the therapeutic value of the drug, but when one considers the fact that THC (Tetrahydrocannabinol, the active ingredient in Marijuana) is denied this sort of research exemption, despite the fact that therapeutic effects have been fairly conclusively shown with Glaucoma and Multiple Sclerosis, as well as indications that it, much like MDMA, might be effective in the treatment of PTSD, it seems to me that something is seriously out of kilter with this process.

*I Love It when I get to go all Doctor McCoy!!!

Great, I Just Got Caught Up in the Patriot Act

No Comments

I was getting some medicine containing some Pseudoephedrine HCL, and because of a glitch with a card swipe, their computer had me getting it, so I could not get another dose for 24 hours.

You wee, when the Patriot Act was reauthorized in 2006, it included legislation that made it tougher to buy Sudafed than it is to buy Plutonium.

After an hour of trying to fix the computer glitch, I left without the decongestant (Zyrtec® D).

F%$# the Patriot Act, and F%$# every F%$#ing member of Congress who F%$#ing voted for this F%$#ing piece of Sh%$ legislation, either the original, or the renewal.

Where I Was Yesterday

No Comments

I was kind of out of it after Saturday’s Trial by Fire, which I put down to rushing, the high humidity, and the fact that I did not eat until 6pm.

It turned out to be a bit more than that.

Yesterday evening, my forearms and calves began to hurt, and I was feeling too crappy to post.

When juxtaposed with the sore throat and cough that I’ve had for the past 2 weeks, had me worried about something like meningitis.

Even though I have a doctor’s appointment later this week, I went to the local clinic at my wife’s insistence.

The doctor saw me, and prescribed antibiotics for my sore throat, a short series of corticosteroids, and a cough medicine.

He also told me to lay off both the statin and the niacin that I am taking, as muscle pain of this sort is a not uncommon side effect for both drugs.

After picking the prescription, and taking all the pills, I sacked out for 4 hours.

When I woke up, I felt a lot better.  I still have a bit of pain, but I feel normal, and my sore throat is gone (indicating that it was bacterial).

I need to take a fasting blood test tomorrow to check muscle enzyme levels.  (CPK)

So, I appear to be all better, so there will be further bloggy goodness, though with Charlie’s Bar Mitzvah on Saturday, it will be light posting.

There are Really Evil People in Kansas

1 Comment

Case in point, most of the members of the Kansas State Board of Healing Arts, who are attempting to strip a doctor’s license for not forcing a 10 year old girl with mental health issues to carry her uncle’s baby to term:

The Kansas State Board of Healing Arts, the governing body that regulates the practice of medicine in the state, stripped the medical license of a woman who refused to force a mentally-ill 10 year old to give birth.

As Robin Marty reports, Dr. Ann Neuhaus became the target of domestic terror group Operation Rescue after her colleague, Dr. George Tiller, was murdered. Neuhaus assisted Tiller by providing second opinions for mental health exceptions for late-term abortions.

Operation Rescue filed a negligence complaint against Neuhaus alleging that her exams were not thorough enough to support her medical conclusions and her follow-up care was inadequate because she did not recommend counseling or hospitalization after each procedure.

Neuhaus offered a rebuttal of her own. “To even claim that isn’t medically necessary qualifies as gross incompetence,” said Neuhaus. “Someone’s 10 years old, and they were raped by their uncle and they understand that they’ve got a baby growing in their stomach and they don’t want that. You’re going to send this girl for a brain scan and some blood work and put her in a hospital?”

Seriously, these are deeply evil religious zealots, and they are way closer to terrorists who intend to strike in the United States than most of the threats that the FBI manufactures.

I’m not hoping for drone strikes against these folks, but it’s clear that there are more direct links to terrorism with Operation Rescue than there is with, for example, the now shuttered Holy Land Foundation.

A Saint’s Bones, Ronald Reagan’s Blood, It’s All the Same

No Comments

It appears that someone has found an old vial of Reagan’s blood, and is selling it:

Ronald Reagan’s foundation expressed outrage on Monday at a British company’s auction of what it says is a vial of the late U.S. president’s blood taken at the hospital where he was treated after a 1981 assassination attempt.

PFC Auctions, a company based in Guernsey in the United Kingdom, announced on Sunday that it would sell the vial of blood in an online auction set to end on Thursday.

The vial was taken at George Washington University Hospital on March 30, 1981, after Reagan was wounded by John Hinckley Jr. in Washington, D.C., PFC Auctions said on its website. It is said to have come from a person whose late mother had worked at a medical lab.

“If indeed this story is true, it’s a craven act and we will use every legal means to stop its sale or purchase,” John Heubusch, executive director of the Ronald Reagan Presidential Foundation, said in a statement.

The website for PFC Auctions said the latest online bid for the vial stood at 6,270 British pounds ($9,910). A PFC Auctions representative could not be reached for comment.

I guess that this is the Republican equivalent of a piece of the true cross, or Jesus’ foreskin.  (Yes, Virginia, one of the medieval scams was his foreskin.)

BTW, here is the kicker:

The seller said he or she had contacted the California-based Ronald Reagan Library and Museum, which is run by the late president’s foundation, months ago and had been told that Reagan’s family would like to have the vial given to them.

“I told him that I didn’t think that was something that I was going to consider … and that I was a real fan of Reaganomics and felt that President Reagan himself would rather see me sell it rather than donating it,” the statement said.

H/t Ed Kilgore. BTW, read the comments on the his post, they are hysterical.